Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

AOC 1001 (del-desiran) - Phase 3 | RNA Pipeline | CatalystAlert

AOC 1001 (del-desiran)

Phase 3

Avidity Biosciences, Inc. (RNA)

50%

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Mar 2026~

RNA⭐Phase 3Phase 3

AOC 1001 (del-desiran) Phase 3 Results Expected

AOC 1001 (del-desiran) • DM1

Drug Information

Target Indication

DM1

Clinical Trial

Last updated: 12/4/2025

Developer

RNA

Avidity Biosciences, Inc.

Biotechnology•North America•NASDAQ